News
Fluent BioSciences Awarded NIH SBIR Grant to Revolutionize Single Cell Analysis
WATERTOWN, Mass., Sept. 12, 2023 /PRNewswire/ — Fluent BioSciences, a cutting edge life sciences company leading the charge in revolutionizing single cell analysis through simple, cost-effective, and highly scalable single-cell RNA sequencing solutions is thrilled to announce the award of an NIH Small Business Innovation Research (SBIR) Phase II grant, funded by the National Institute of General Medical […]
Fluent BioSciences Partners with Genspace to Unleash the Power of PIPseq™: Empowering Community Scientists to Transform Genomic Research
WATERTOWN, Mass., May 30, 2023 /PRNewswire/ — Fluent BioSciences, a life science tools company, delivering single-cell technology to laboratories across the United States and abroad, collaborates with Genspace by sponsoring a community science workshop in Brooklyn, NY. They hope to empower scientists by breaking down barriers in a field which has previously been marred by prohibitive costs and expertise requirements. At […]
Fluent BioSciences Partners with GenomeWeb and NYU Grossman School of Medicine’s Liddelow Lab to Host Webinar on Revolutionary PIPseq scRNA-Seq Technology with Upcoming bioRxiv Publication
Watertown, MA, May 16, 2023 – Fluent BioSciences, a top life sciences company focusing on bringing the benefits of high-quality single-cell biology to all laboratories by offering scalable, cost-effective, and easy-to-implement scRNA-seq solutions, in collaboration with GenomeWeb and the Liddelow Lab, will host a webinar to explore the use of PIPseq, an innovative single-cell RNA […]
Fluent BioSciences Releases Comprehensive White Paper Highlighting Increased Performance Metrics with the Latest v4.0 PIPseq Single Cell RNA Sequencing Kits
Fluent BioSciences, a leading life sciences company focused on revolutionizing single cell analysis through simple, cost effective and scalable solutions, has published a white paper highlighting the performance improvements of the recently announced v4.0 chemistry as compared to the previous v3.0 chemistry. The v4.0 chemistry enables users to achieve higher capture rates, significantly higher sensitivity […]
Fluent BioSciences announces Nature Biotechnology journal publication, “Microfluidics-free single-cell genomics with templated emulsification”, showcasing the foundational technology underlying PIPseq™
The Nature Journal publication follows the recent release of Fluent’s v4.0 chemistry with significant performance enhancements and the highest cell capture rate in the market. Watertown, MA, March 7, 2023 – Fluent BioSciences, a leading life sciences company focused on revolutionizing single cell analysis through simple, cost-effective and scalable solutions, announces the Nature Biotechnology Journal […]
Fluent BioSciences announces PIPseq™ v4.0 chemistry with significant performance enhancements and the highest cell capture rate in the single cell market at the 2023 AGBT conference
Fluent will be presenting a poster highlighting the PIPseq technology and customer case studies of projects enabled by the highly scalable portfolio of 3′ Single Cell RNA Kits WATERTOWN, Mass., Feb. 6, 2023 /PRNewswire/ — Fluent BioSciences, a leading life sciences company focused on revolutionizing single cell analysis through simple, cost effective and scalable solutions, announces the […]
Fluent BioSciences Showcasing Breakthrough Solutions at the 2022 ASHG Conference
The PIPseq™ portfolio of kits enable any researcher to easily perform a broad range of single-cell transcriptomic applications in a single reaction with no expensive capital equipment Watertown, MA, October 25, 2022 – Fluent BioSciences, a life sciences company focused on making single-cell analysis simple and accessible to every researcher, announced it will be presenting […]
Fluent BioSciences launches industry’s first single tube 100,000 cell product to enable unprecedented scale, cost-efficiency and access for single-cell RNA sequencing
The PIPseq™ T100 kits enable any researcher to easily perform large, complex single-cell transcriptomic applications in a single reaction with no expensive capital equipment Watertown, MA, September 27, 2022 – Fluent BioSciences, a life sciences company focused on making single-cell analysis simple and accessible to every researcher, announces the launch of a novel 100,000 cell […]
Fluent BioSciences launches industry’s most accessible, cost-effective and scalable technology (PIPseq™) to accelerate adoption of single-cell RNA sequencing in any laboratory
Priced as low as $300 per reaction, the T2 and T20 kits enable any researcher to immediately access the power of single-cell transcriptomics with no capital investment WATERTOWN, Mass., June 23, 2022 /PRNewswire/ — Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every researcher, announced the launch of two new breakthrough products for […]
Fluent BioSciences and NanoCellect announce joint collaboration to improve resolution of single-cell RNA sequencing analysis of rare cell populations
Watertown, MA, June 17, 2022 – Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every researcher, and NanoCellect Biomedical, Inc., a leader in the development and manufacturing of innovative and affordable solutions for cell sorting, jointly announced a collaboration to improve resolution and efficiency of single-cell RNA sequencing (scRNA-seq) […]